Literature DB >> 15810001

A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome.

David J Hur1, Gerald V Raymond, Stephen G Kahler, Douglas L Riegert-Johnson, Bernard A Cohen, Simeon A Boyadjiev.   

Abstract

Keutel syndrome (KS) [OMIM 245150] is a rare autosomal recessive condition, characterized by abnormal cartilage calcification. Mutations in the matrix Gla protein gene (MGP) have been previously reported in three unrelated KS families. MGP is an extracellular matrix protein that acts as a calcification inhibitor by repressing bone morphogenetic protein 2 (BMP2). Loss-of-function mutations of MGP result in abnormal calcification of the soft tissues, a cardinal feature of KS. We report the fourth MGP mutation (IVS2 + 1G > A) in a consanguineous Arab family, which results in the loss of the consensus donor splice site at the exon 2-intron 2 junction. In addition to the typical manifestations, we observed abnormalities in the white matter of the brain, optic nerve atrophy, and mid-dermal elastolysis in the affected individuals of this family. This report broadens the clinical phenotype observed in patients with KS. The effect of the IVS2 + 1G > A mutation is consistent with the previously reported loss-of-function mutations of MGP. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810001     DOI: 10.1002/ajmg.a.30680

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

Review 1.  The dualistic role of vitamin D in vascular calcifications.

Authors:  M Shawkat Razzaque
Journal:  Kidney Int       Date:  2010-10-20       Impact factor: 10.612

2.  The association of matrix Gla protein isomers with calcification in capsules surrounding silicone breast implants.

Authors:  Larry W Hunter; John C Lieske; Nho V Tran; Virginia M Miller
Journal:  Biomaterials       Date:  2011-08-11       Impact factor: 12.479

3.  Petrified ears in a patient with Keutel syndrome: temporal bone CT findings.

Authors:  Hemant Parmar; Susan Blaser; Sheila Unger; Shi-Joon Yoo; Blake Papsin
Journal:  Pediatr Radiol       Date:  2005-11-18

4.  Cloning of matrix Gla protein in a marine cartilaginous fish, Prionace glauca: preferential protein accumulation in skeletal and vascular systems.

Authors:  J B Ortiz-Delgado; D C Simes; C S B Viegas; B J Schaff; C Sarasquete; M L Cancela
Journal:  Histochem Cell Biol       Date:  2006-01-13       Impact factor: 4.304

Review 5.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

6.  Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia.

Authors:  Juliana Marulanda; Hazem Eimar; Marc D McKee; Michelle Berkvens; Valentin Nelea; Hassem Roman; Teresa Borrás; Faleh Tamimi; Mathieu Ferron; Monzur Murshed
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

7.  Matrix GLA protein function in human trabecular meshwork cells: inhibition of BMP2-induced calcification process.

Authors:  Wei Xue; Reidar Wallin; Elizabeth A Olmsted-Davis; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

8.  A Novel MGP Gene Mutation Causing Keutel Syndrome in a Brazilian Patient.

Authors:  Eduardo Perrone; Kelin Chen; Marco Ramos; Maria Fernanda Milanezi; Viviane Nakano; Ariane Falconi; Juliana Silva; Jamille Campos; Celia M C Silva; Joao B O Filho; Ana B A Perez
Journal:  Mol Syndromol       Date:  2018-04-25

9.  The mapping of DFNB62, a new locus for autosomal recessive non-syndromic hearing impairment, to chromosome 12p13.2-p11.23.

Authors:  G Ali; R L P Santos; P John; M A L Wambangco; K Lee; W Ahmad; Sm Leal
Journal:  Clin Genet       Date:  2006-05       Impact factor: 4.438

Review 10.  Evidence for a calcification process in the trabecular meshwork.

Authors:  Teresa Borrás; Núria Comes
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.